ARF6 and AMAP1 are major targets of KRAS and TP53 mutations to promote invasion, PD-L1 dynamics, and immune evasion of pancreatic cancer
Article in Proceedings of the National Academy of Sciences of the United States of America (August 2019)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in Proceedings of the National Academy of Sciences of the United States of America (August 2019)
Article in Oncology Research and Treatment (September 2018)
Article in World Journal of Gastroenterology (December 2017)